Brain Talk | Being Patient for Alzheimer's Patients and Caregivers

🔥The 5 BIGGEST breakthroughs of 2023 in Alzheimer’s and dementia. 🚀 From the FDA's full approval of Leqembi, a game-changing Alzheimer's drug, to the revolutionary potential of PET scans in diagnosing Alzheimer's, get ready for groundbreaking news in #Alzheimer's and #dementia research💡 But that's not all—get ready to learn about direct-to-consumer blood tests, cutting-edge...

Award-winning dementia researcher and educator Dr. Nir Grossman joins Being Patient Live Talks to talk about the potential of cutting-edge medical technology like deep brain stimulation as an emerging approach to treating neurodegenerative diseases like Alzheimer’s. Grossman is an associate professor at the Department of Brain Sciences at Imperial College London and a founding fellow of the UK Dem...

The key to understanding Alzheimer’s disease could be in our genes. While the cause of Alzheimer’s is still unknown, mounting research shows that carrying multiple copies of certain genes — like genetic variant ApoE4 — can significantly increase the likelihood of developing Alzheimer’s. By studying genetics and gene therapy, scientists are learning more about how genes play a role in Alzheimer’s d...

Xanax and other benzodiazepines (“benzos”) are often prescribed to treat symptoms like agitation, anxiety, and depression in people living with dementia. Yet, these drugs come with significant side effects and safety concerns, especially for older adults living with dementia. The Women’s Age Lab’s Dr. Paula Rochon and Dr. Christina Reppas-Rindlisbacher join Being Patient Live Talks to discuss why...

Classical music publicist, educator, performer, and dementia advocate Mary Lou Falcone joins Being Patient Live Talks to discuss her book, I Didn’t See It Coming. In this memoir of “love, loss, and Lewy Body dementia,” Falcone details the caregiving journey for her late husband, Nicholas ‘Nicky’ Zann, whose illustrations introduce each chapter. Falcone is an internationally known classical music p...

The key to understanding Alzheimer’s disease could be in our genes. While the cause of Alzheimer’s is still unknown, mounting research shows that carrying multiple copies of certain genes — like genetic variant ApoE4 — can significantly increase the likelihood of developing Alzheimer’s. By studying genetics and gene therapy, scientists are learning more about how genes play a role in Alzheimer’s d...

Mild Cognitive Impairment (MCI) is associated with early stages of neurodegenerative diseases like Alzheimer’s and other dementias. Many people living with dementia cite symptoms of MCI as an early sign. Yet, there’s lots of confusion with what might be “normal” memory loss that comes with aging or a sign to see a doctor. UCSF’s Emily Paolillo, PhD, joins Being Patient Live Talks to explain MCI an...

Navigating the holidays with dementia can be challenging, especially when it comes to travel. When designing a holiday trip, there are key strategies that caregivers can take in planning all of the trips this season may require. Dr. Alexis Eastman, a clinical associate professor at the University of Wisconsin School of Medicine, joins Being Patient Live Talks to discuss best practices for holiday...

atching and accurately identifying a neurodegenerative disease like Alzheimer’s or another form of dementia early can make all the difference in the world to a patient and their loved ones: An early diagnosis means more time to plan for the future, join a clinical trial testing cutting-edge disease-modifying treatments, making lifestyle changes to slow symptoms, or spending more time with loved on...

Writer, advocate, and international speaker Laurie Scherrer joins Being Patient Live Talks to discuss her experience living with early onset Alzheimer’s and FTD. After being diagnosed with early-onset Alzheimer’s and frontotemporal dementia at age 55, Scherrer started the blog Dementia Daze to share her journey and help others through their dementia journey. Writing about her feelings, challenges,...

This video was made possible through sponsorship by Lexeo Therapeutics. Being Patient’s editorial team produced the interview and article, with no review/approval process by the sponsor. Lexeo Therapeutics: https://www.lexeotx.com/ Pioneering genetic medicine expert and physician Ronald G. Crystal of Cornell University’s Weill Medical College joins Being Patient’s editor in chief Deborah Kan for a...

Being Patient speaks with Benjamin Bikman, professor of cell biology and physiology at Brigham Young University, about the complex processes of our metabolism, and how metabolic health plays a role in neurodegenerative diseases like Alzheimer’s and our brain health. We rely on donations to bring you the latest research on dementia and brain health and to support our amazing team of independent jou...

Doctor and New York Times bestselling author Sandeep Jauhar joins Being Patient Live Talks to discuss his latest book, “My Father’s Brain,” in which he shares an account of his father’s journey with Alzheimer’s alongside his own experience coming to understand the disease through caring for his father. Watch the full live talk to learn more about his experience caretaking and writing the book. You...

Virginia Tech’s Dr. Julia C. Basso joins Being Patient Live Talks to discuss her work studying the body-brain connection through dance, yoga, and meditation. As an assistant professor in the Department of human nutrition, foods, and exercise at Virginia Tech, Basso’s research is focused on the body-brain connection and utilizing the body to boost brain function and physiology. With a background in...

Dr. Valter Longo of the University of Southern California returns to Live Talks to discuss his research on fasting and brain health. In his previous Live Talk with Being Patient, Longo discussed how fasting could be the most potent way to activate rejuvenation processes in the body and lower the risk of disease. Longo is internationally recognized as a leader in the field of aging studies and rela...

Teepa Snow, MS, OTR/L, FAOTA is an Occupational Therapist with over 40 years of clinical and academic experience. Her life’s mission is to shed a positive light on dementia, which is why she founded the GEMS State Model for understanding the progression of dementia and the Positive Approach® training strategies. Her company, Positive Approach to Care (PAC) provides online and in-person education a...

The Amazing Grace Chorus is a Milwaukee-based community chorus organized by the Wisconsin Alzheimer’s Institute. Through artistic musical expression, social engagement, and access to resources, the program seeks to improve the quality of life of individuals and their care partners and focuses on stigma reduction in the community. The chorus will be celebrating its eight year anniversary and k...

On Friday, February 3rd 11:00 a.m. PT/2:00 p.m. ET USC quantitative neuroscientist, gerontologist, and biomedical engineer Dr. Andrei Irimia joins Being Patient Live Talks to discuss his research on brain aging and AI technology.   Irimia’s research uses computational biology approaches and multimodal imaging to study brain aging in health and disease. In his latest research, USC researc...

Dr. Valter Longo of the University of Southern California returns to Live Talks to discuss his research on fasting and brain health. In his previous Live Talk with Being Patient, Longo discussed how fasting could be the most potent way to activate rejuvenation processes in the body and lower the risk of disease.  Longo is internationally recognized as a leader in the field of aging studies an...

Chopp, a widely published author, editor, and academic, is currently the Chancellor Emerita of the University of Denver and the former President of both Colgate University and Swarthmore College. She was diagnosed with Alzheimer’s in 2019, and over the past few years, has become an accomplished painter. Her upcoming book, Art, Spirit, Body: Ways to Live While Dying from Alzheimer’s, is an inspirat...

Being Patient speaks with C-Suite business and biotech leader Wendy Nelson, PhD, about her discovery that she carries two copies of Alzheimer’s genetic biomarker APOE4, a gene variant associated with heightened Alzheimer’s risk, and the way this revelation has changed the way she thinks about brain health.   Nelson is currently the chief business officer for a strategic advisory company in th...

When Gordon Van Slyke, 75, decided to participate in the phase drug trials for Eisai and Biogen’s new monoclonal antibody drug Leqembi (lecanemab), it was his family history with Alzheimer’s that motivated him. Read more about his story: https://www.beingpatient.com/lecanemab-leqembi-trial-participant-story/ 

Michele Hall was diagnosed with early-onset Alzheimer's in her early fifties. Deborah talks to her about the process of her diagnosis and her experience with Aduhelm.    We rely on donations to bring you the latest research on dementia and brain health and to support our amazing team of independent journalists. Please consider donating to support of our mission of giving people impacted...

Former trial attorney Dale Rivard, 64, shares his story of living fully with a diagnosis of mild cognitive impairment.  We rely on donations to bring you the latest research on dementia and brain health and to support our amazing team of independent journalists.  Please consider donating to support of our mission of giving people impacted by dementia a better resource and connection to e...

James Russell, whose daughter Lynne Russell is living with early-onset Alzheimer's, shares his family's story of love, care and resilience.   For more about James' blog: https://neverthelessdementiawepersist.com/ We rely on donations to bring you the latest research on dementia and brain health and to support our amazing team of independent journalists. Please consider donating to suppor...